Huntsman Cancer Institute PathMaker Programs for Cancer Research
亨斯迈癌症研究所癌症研究 PathMaker 计划
基本信息
- 批准号:10474257
- 负责人:
- 金额:$ 54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:18 year oldAddressAgeAlaska NativeAmericanAmerican IndiansAwarenessBasic ScienceBehavioral ResearchBiomedical ResearchCancer Research ProjectCitiesClinicalClinical ResearchCollaborationsCommunitiesCommunity OutreachEducationEducation ProjectsEducational process of instructingEnsureEvaluationEventFaceFamilyFosteringFuture TeacherGoalsHigh School StudentHispanicHomeIndividualInfluentialsInstitutesInstructionInterest GroupInternationalLaboratory ResearchLatinoLatino PopulationLearningLifeMalignant NeoplasmsMedical StudentsMentorsMiddle School StudentMinority GroupsNCI-Designated Cancer CenterNational Cancer InstituteNative Hawaiian or Other Pacific IslanderPacific IslanderParticipantPersonsPhysiciansPopulationPopulation SciencesPreparationPreventionPrevention educationProgram DevelopmentResearchResearch TrainingScienceScience of geneticsScientistScreening for cancerSodium ChlorideSpecialistStudentsTrainingTraining ProgramsTraining and EducationTribesUnderrepresented PopulationsUnderrepresented StudentsUniversitiesUtahWorkanticancer researchcancer health disparitycareercareer networkingcohortcommunity buildingcommunity settingcurriculum developmenteducation researchexperiencehealth inequalitieshigh schoolhigh school programinnovationinterestjunior high schoollearning materialsmembernoveloutreachoutreach programprogramsranpirnaserecruitresearch and developmentrole modelscience educationscience teacherscreeningskillssupport networkteacherundergraduate studentunderserved communityweb site
项目摘要
The overarching goal of this R25 application is to enhance the diversity of the pool of individuals from
underrepresented groups interested in pursuing careers in biomedical and cancer-related research by
providing research experiences for high school and undergraduate students, research and curriculum
development experiences for middle and high school science teachers, and outreach to middle school
students, their families, and their communities. The Huntsman Cancer Institute PathMaker Programs for
Cancer Research will bring exceptional cancer research training pipeline programs to Utah and the Mountain
West to support the National Cancer Institute’s R25 program goal of increasing diversity of the biomedical,
behavioral, and clinical research workforce. The proposed program, building on successful P30 CURE and
FRTEP Supplements, will comprise three interrelated and complementary components: PathMaker Scholars,
PathMaker Bridge, and PathMaker Connect. PathMaker Scholars is a mentored cancer research experience
for high school and undergraduate students; PathMaker Bridge provides mentored cancer research
experiences and guided curriculum development for middle and high school science teachers, providing a
bridge to their students; with PathMaker Connect we will connect HCI and the two previously-mentioned
groups to a specific community through an innovative outreach event. While applicants from all groups
underrepresented in biomedical research will be encouraged and welcomed, recruiting efforts will focus on
students who belong to one of three minority groups significant to Utah and Salt Lake City: Hispanic/Latino,
American Indian or Alaska Native, or Native Hawaiian or Pacific Islander. Hispanic/Latinos comprise Utah’s
largest minority population, with 14% of the overall population and nearly 18% of the population under 18 years
of age. Also, Utah is home to eight American Indian tribes or nations, and a surprisingly large Pacific Islander
population including one-fourth of all Tongan Americans. These groups are massively underrepresented in
biomedical research, and they face significant cancer-related health disparities. This project will be led by a
team comprising a physician scientist and a basic scientist, who have relevant experience in programs to
increase diversity in biomedical research careers, career mentoring, and biomedical research career training.
Student research experiences will be enhanced by a rich professional preparation and community-building
program. Additionally, PathMaker Bridge will partner with the internationally-recognized University of Utah
Genetic Science Learning Center (GSLC) to provide an exceptional professional development program to
guide teacher participants in using their research experiences to create novel curricular materials, with the
potential for world-wide dissemination on the GSLC website. A professional evaluator will provide formative
and summative evaluation to ensure the program achieves its maximum potential.
此R25应用程序的首要目标是增强个人池的多样性,
有兴趣从事生物医学和癌症相关研究的代表性不足的群体,
为高中和本科生提供研究经验,研究和课程
初中和高中科学教师的发展经验,以及对中学的推广
学生,他们的家庭和社区。亨斯迈癌症研究所PathMaker项目
癌症研究将带来特殊的癌症研究培训管道计划,犹他州和山区
西支持国家癌症研究所的R25计划的目标,增加生物医学,
行为学和临床研究人员。拟议的计划,建立在成功的P30 CURE和
FRTEP补充,将包括三个相互关联和互补的组成部分:PathMaker学者,
PathMaker Bridge和PathMaker Connect。PathMaker Scholars是一个有指导的癌症研究体验
为高中生和本科生; PathMaker Bridge提供指导性癌症研究
经验和指导课程开发的初中和高中科学教师,提供了一个
与学生建立联系;使用PathMaker Connect,我们将连接HCI和前面提到的两个
通过创新的外展活动,向特定的社区提供服务。虽然来自所有群体的申请人
在生物医学研究中代表性不足将受到鼓励和欢迎,招聘工作将集中在
属于对犹他州和湖城重要的三个少数民族之一的学生:西班牙裔/拉丁裔,
美洲印第安人或阿拉斯加原住民,或夏威夷原住民或太平洋岛民。西班牙裔/拉丁裔构成了犹他州的
少数民族人口最多,占总人口的14%,18岁以下人口的近18%
年龄。此外,犹他州是八个美洲印第安部落或民族的家园,还有一个令人惊讶的大太平洋岛民
人口包括四分之一的汤加裔美国人。这些群体在非洲的代表性严重不足,
他们面临着与癌症相关的健康差距。该项目将由一名
团队由一名医生科学家和一名基础科学家组成,他们在项目方面具有相关经验,
增加生物医学研究职业、职业指导和生物医学研究职业培训的多样性。
学生的研究经验将通过丰富的专业准备和社区建设得到加强
程序.此外,PathMaker Bridge还将与国际知名的犹他州大学合作
遗传科学学习中心(GSLC)提供卓越的专业发展计划,
指导教师参与者利用他们的研究经验来创建新的课程材料,
有可能在GSLC网站上向全世界传播。专业评估人员将提供形成性的
和总结性评估,以确保该计划实现其最大潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald E Ayer其他文献
Donald E Ayer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald E Ayer', 18)}}的其他基金
Huntsman Cancer Institute (HCI) Cancer Genetics, Epigenetics, Models, and Signaling (Cancer GEMS) Training Program
亨斯迈癌症研究所 (HCI) 癌症遗传学、表观遗传学、模型和信号传导(癌症 GEMS)培训计划
- 批准号:
10627604 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
亨斯迈癌症研究所癌症研究 PathMaker 计划
- 批准号:
9792209 - 财政年份:2019
- 资助金额:
$ 54万 - 项目类别:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
亨斯迈癌症研究所癌症研究 PathMaker 计划
- 批准号:
10661674 - 财政年份:2019
- 资助金额:
$ 54万 - 项目类别:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
亨斯迈癌症研究所癌症研究 PathMaker 计划
- 批准号:
10005296 - 财政年份:2019
- 资助金额:
$ 54万 - 项目类别:
Transcriptional control of skeletal muscle insulin resistance
骨骼肌胰岛素抵抗的转录控制
- 批准号:
8299142 - 财政年份:2010
- 资助金额:
$ 54万 - 项目类别:
Transcriptional control of skeletal muscle insulin resistance
骨骼肌胰岛素抵抗的转录控制
- 批准号:
8463513 - 财政年份:2010
- 资助金额:
$ 54万 - 项目类别:
Transcriptional control of skeletal muscle insulin resistance
骨骼肌胰岛素抵抗的转录控制
- 批准号:
7918568 - 财政年份:2010
- 资助金额:
$ 54万 - 项目类别:
Transcriptional control of skeletal muscle insulin resistance
骨骼肌胰岛素抵抗的转录控制
- 批准号:
8076333 - 财政年份:2010
- 资助金额:
$ 54万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
Research Grant